Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Applied Clinical Pediatrics ; (24): 1269-1272, 2015.
Article in Chinese | WPRIM | ID: wpr-480159

ABSTRACT

Objective To evaluate the effects of PM2.5 on the differentiation of splenic CD4 + T lymphocytes in acute asthma mice.Methods (1) Mouse models of acute asthma were established by ovalbumin (OVA) sensitization and challenge.(2) PM2.5 was collected in the urban area of Zhanjiang city under heavy traffic and serious air pollution from total suspended particulate(TSP) mid-flow sampler and multistage particles cutters and the dry powder of PM2.5 was prepared.(3) Specific-pathogen free Balb/c mice,female,at 6 to 8 weeks of age were randomly divided into 8 groups (8 mice each group):a negative control group (NC group),asthma control group (AC group),sensitized mice treated with different doses of PM2.5 groups (SP groups) and asthmatic mice treated with different doses of PM2.5 groups (AP groups).SP groups and AP groups were respectively divided into 3 subgroups according to the dose of PM2.5.The AC group,SP groups and AP groups were sensitized on D0,D7 and D14,and the NC group was treated with NS as controls.The SP1/AP1 group,SP2/AP2 group and SP3/AP3 group were respectively given 50 μL PM2.5 suspension.NC group and AC group were instilled with NS as controls.AC group and AP groups were challenged by aerosol of OVA,and NC group and SP group were treated with NS as controls.Twenty-four hours after last challenge,all the mice were sacrificed,and the percentage of regulatory T cells (Treg),T helper cell type 1 (Th1),Th2 and Th17 of splenic CD4 + T lymphocytes was detected by flow cytometry (FCM).Results (1) An OVA-induced mouse models with acute asthma were successfully established.(2) Comparison of the percentage of Treg of splenic CD4 + T lymphocytes:SP group [(12.28 ± 0.73) %,(11.93 ± 0.81) % and (11.70-± 1.14) %] and AC group [(12.18 ± 1.00) %] were lower than that in the NC group[(13.50 ± 0.39) %] (P < 0.05),AP3 group [(10.58 ± 0.65) %] was lower than that in the AC group and AP1 group [(11.91 ± 0.79) %] (P < 0.05).(3) Comparison of the ratio of Th1/Th2 of splenic CD4+ T lymphocyte:SP1 group [(7.74 ± 1.21)%] was higher than that in the NC group [(5.52 ± 1.06) %] (P <0.05),SP2 group[(6.30 ±0.58) %] was lower than that in the SP1 group(P <0.05),SP3 group [(4.87 ± 0.82) %] was lower than that in the SP2 group (P < 0.05);AC group [(3.69-± 0.47) %] was lower than that in the NC group and SP3 group (P < 0.05);AP3 group [(2.92 ± 0.57) %] was lower than that in the AC group(P < 0.05).(4) Comparison of the percentage of Th17 of splenic CD4+ T lymphocyte:AP3 group [(1.46 ± 0.39) %] was higher than that in the NC group [(0.89 ± 0.24) %] and the AP2 group [(0.83 ± 0.15) %] (P < 0.001).Conclusions PM2.5 can inhibit splenic CD4 + T lymphocyte of acute asthma mice differentiation into Treg and Th1,and promote their differentiation into Th2 and Th17,through which aggravates inflammation reactions in the airway.

2.
China Journal of Traditional Chinese Medicine and Pharmacy ; (12)2005.
Article in Chinese | WPRIM | ID: wpr-568004

ABSTRACT

Objective: Xiaoliu Granule (XLG) is based on the principle of Yiqi Huayu Decoction, this experiment was to study the treating point of XLG on the hysteromyoma rats. Methods: The hysteromyoma rats models was established in rats by loading estrogen and progesterone, to observe the effect of XLG on pathological condition of uterus, and the content of PR , ER, Bcl-2/Bax. Results: The experiments proved that XLG was effective in reducing the proliferation, reversing the proliferative abnormalities of uterus smooth muscle. The XLG also can significantly reduce the content of PR, ER and Bcl-2/Bax. Conclusion: Therefore, XLG was a good approach in treating hysteromyoma. The mechanism of XLG in treating hystermyoma was probably by reducing ER, PR, lowering the E, P sensitivity; reducing expression of Bcl-2, increasing the expression of Bax, and promoting cell apoptosis, etc.

SELECTION OF CITATIONS
SEARCH DETAIL